Colostomy is a simple and effective procedure for severe chronic radiation proctitis

Abstract

AIM: To assess the efficacy and safety of diverting colostomy in treating severe hemorrhagic chronic radiation proctitis (CRP).

METHODS: Patients with severe hemorrhagic CRP who were admitted from 2008 to 2014 were enrolled into this study. All CRP patients were diagnosed by a combination of pelvic radiation history, clinical rectal bleeding, and endoscopic findings. Inclusion criteria were CRP patients with refractory bleeding with moderate to severe anemia with a hemoglobin level < 90 g/L. The study group included patients who were treated by diverting colostomy, while the control group included patients who received conservative treatment. The remission of bleeding was defined as complete cessation or only occasional bleeding that needed no further treatment. The primary outcome was bleeding remission at 6 mo after treatment. Quality of life before treatment and at follow-up was evaluated according to EORTC QLQ C30. Severe CRP complications were recorded during follow-up.

RESULTS: Forty-seven consecutive patients were enrolled, including 22 in the colostomy group and 27 in the conservative treatment group. When compared to conservative treatment, colostomy obtained a higher rate of bleeding remission (94% vs 12%), especially in control of transfusion-dependent bleeding (100% vs 0%), and offered a better control of refractory perianal pain (100% vs 0%), and a lower score of bleeding (P < 0.001) at 6 mo after treatment. At 1 year after treatment, colostomy achieved better remission of both moderate bleeding (100% vs 21.5%, P = 0.002) and severe bleeding (100% vs 0%, P < 0.001), obtained a lower score of bleeding (0.8 vs 2.0, P < 0.001), and achieved obvious elevated hemoglobin levels (P = 0.003), when compared to the conservative treatment group. The quality of life dramatically improved after colostomy, which included global health, function, and symptoms, but it was not improved in the control group. Pathological evaluation after colostomy found diffused chronic inflammation cells, and massive fibrosis collagen depositions under the rectal wall, which revealed potential fibrosis formation.

CONCLUSION: Diverting colostomy is a simple, effective and safe procedure for severe hemorrhagic CRP. Colostomy can improve quality of life and reduce serious complications secondary to radiotherapy.

Key Words: Chronic radiation proctitis; Rectal bleeding; Diverting colostomy; Quality of life; Serious complication

Core tip: The study describes the efficacy and safety of diverting colostomy in treating severe hemorrhagic chronic radiation proctitis. The procedure focuses on improving the severe refractory bleeding and reducing severe complications. The advantages of diverting colostomy are as follows: it acts effectively and rapidly in controlling severe bleeding that does not respond to conservative treatment; it is a simple procedure that can be conducted in many medical centers; and it can improve quality of life dramatically and reduce serious complications that occur secondary to radiotherapy.

INTRODUCTION

Chronic radiation proctitis (CRP) is a common complication after radiotherapy of pelvic malignancies, accounting for 5%-20% of cases[1]. The onset of RP can be delayed for several months to years after radiotherapy. CRP develops as a result of ischemic lesions due to obliterative endarteritis and progressive fibrosis[2,3]. Rectal bleeding is the most common symptom, which accounts for > 80% of CRP patients[4]. Acute and mild CRP is usually self-limiting and easy to manage, but moderate to severe CRP is difficult to treat; especially those cases requiring blood transfusions and that are life threatening[1,5].

Various treatment modalities have been tried. Medical agents include topical sucralfate, steroids[6], sulfasalazine[7], metronidazole[8], rebamipide[9] and short-chain fatty acid[10]. Other treatment options include topical formalin[11,12], endoscopic argon plasma coagulation (APC)[13], laser therapy[14], and hyperbaric oxygen therapy[15]. However, most of these treatments are only useful for mild to moderate bleeding, and severe and refractory bleeding is still problematic[16]. Furthermore, endoscopic treatments can bring severe side effects and multiple treatment sessions are needed for severe CRP[17]. In addition, accompanying symptoms such as intractable perianal pain, urgency and tenesmus in CRP are usually hard to manage.

Diverting colostomy has been reported previously, mainly for severe CRP complications[18,19]. Colostomy can reduce the irritation injury of fecal stream to the irradiated tissues and thus decrease rectal bleeding. However, unlike formalin or APC, colostomy is now not widely used. The issue of colostomy is not well studied to date. To the best of our knowledge, no study has compared diverting colostomy to conservative treatment. The aim of this study was to assess the efficacy and safety of diverting colostomy in severe CRP. The indications, quality of life, severe CRP complications, and stoma reversals after colostomy were also investigated, when compared to conservative treatment.

MATERIALS AND METHODS

Patients and ethical statements

Hemorrhagic CRP patients who were treated at the Sixth Affiliated Hospital of Sun Yat-Sen University (SYSU) from March 2008 to October 2014 were retrospectively enrolled in this study. Electronic files and medical records were both carefully collected to extract clinicopathological data. This study was approved by the Ethical Committee of the Sixth Affiliated Hospital of SYSU and the study was conducted in accordance with the provisions of the World Medical Association’s Declaration of Helsinki in 1995 (revised in Tokyo, 2004). Due to the nature of the retrospective study, informed consent was waived.

Inclusion and exclusion criteria

Inclusion criteria were CRP patients with refractory bleeding with moderate to severe anemia with a hemoglobin level < 90 g/L. Refractory bleeding was defined as no response to conservative treatment. Patients who were treated with diverting stomas were enrolled in the study group, while those who continued to non-surgical treatment were enrolled in the control group. Patients with tumor relapses, loss to follow-up, or who underwent rectal resection with preventive colostomy were excluded.

Diagnosis, scores and definitions

All patients were diagnosed by combination of pelvic radiation history, clinical rectal bleeding, and endoscopic findings of injured rectal mucosa. Flexible colonoscopy was performed in all patients to rule out other causes of bleeding, such as recurrent tumors, inflammatory bowel disease and anal benign hemorrhagic diseases. The Vienna Rectoscopy Score[20] system was used to assess endoscopic severity.

Current scores to evaluate the severity of bleeding included Common Terminology Criteria for Adverse Events[21], Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (EORTC) score[22]. However, most of them are based on subjective complaints of patients, instead of accurate laboratory tests. Because the severity of bleeding was mainly reflected by a decrease in hemoglobin level, we designed a modified Subjective Objective Management Analysis (SOMA) system reported in a previous study[23], to assess the severity of bleeding, included both subjective complaints of bleeding and objective hemoglobin level. All patients were scored by the system (Table 1). The remission of bleeding was defined as complete cessation of bleeding or only occasional bleeding that needed no further treatment. Failure in the conservative treatment group was defined as no improvement or even worse bleeding and decreased hemoglobin level 6 mo after treatment.

Table 1 Modified subjective objective management analysis system to assess the severity of bleeding in radiation proctitis.

Grade	Bleeding	Severity	Anemia (Hb, g/L)
1	Mild bleeding	Occasionally or occult	Mild anemia (Hb: ≥ 90 g/L)
2	Moderate bleeding	Persistent	Moderate anemia (Hb: 70-90 g/L)
3	Severe bleeding	Gross	Severe anemia, transfusion needed (Hb: < 70 g/L)

Hb: Hemoglobin.

Indications of diverting colostomy

All patients, except those with fistulas, were initially treated with medical agent enemas including almagate (one mucosa-protector like sucralfate), corticosteroids, and metronidazole. Topical formalin (details listed in our previous study)[24] or endoscopic APC were suggested when they experienced recurrent bleeding. As for refractory and transfusion-dependent CRP after these conservative measures, physicians suggested a diverting stoma. If patients refused a colostomy and demanded to continue conservative treatment, they were enrolled in the control group. Other indications of diverting colostomy were as follow: (1) fistula, perforation or stricture; and (2) deep ulcer with refractory perianal pain.

Diverting loop colostomies were conducted under general anesthesia in the operating room. The transverse colon was pulled out through a small incision, then a soft catheter of a stent was inserted to prevent stoma retraction, and a double-cavity stoma of the transverse colon was then created. The catheter was removed postoperatively. Classical images of a double-cavity colostomy and a “gunsight” of stoma closure were shown (Figure 1). This technique of stoma closure can simplify wound care, decrease surgical site infection, and give a neat cosmetic result[25,26].

Figure 1 Classic representative images of a double-cavity colostomy. A: A double-cavity colostomy with a soft catheter as a stent; B: A colostomy after during follow-up; C: A “gunsight” skin incision and closure for stoma reversal.

Follow-up

Follow-up was scheduled through outpatient visits or telephone questionnaires at 6 mo and 1 year after treatment. The quality of life before treatment and at follow-up was evaluated according to EORTC QLQ C30[27]. The primary outcome was the remission rate of bleeding at 6 mo after treatment. The secondary outcomes included hemoglobin level, remission rate of bleeding at 1 year after treatment, quality of life, stoma-related complications, severe CRP complications, and stoma reversal rate.

Statistical analysis

Comparisons of characteristics were made by Student’s t test analysis for continuous variables. For categorical variables, the χ² test was used. Fisher’s exact test was adopted when appropriate. For non-parameter variables, the Wilcoxon rank sum test was used. All statistical analyses were performed by SPSS version 17.0 (Chicago, IL, United States). P < 0.05 (two-tails) was considered to be statistically significant.

RESULTS

Demographics and characteristics

A total of 47 patients were analyzed. Twenty-two (46.8%) were treated by diverting colostomy, and 27 (53.2%) were managed by conservative treatment (Figure 2). Forty-three (91.5%) were women, and 40 (85.1%) primary malignancies were cervical cancer. Cumulative radiation dosage of one patient was about 80 Gy, which included the radiation for both sites of primary malignancy and invasive lymph nodes. The detailed radiotherapy for those patients with gynecological cancers, especially cervical cancer, was 25 rounds (2 Gy/round) of external beam radiation and five or six episodes (6 Gy/episode) of intra-cavity brachytherapy. Patients with prostate or rectal cancers received only external beam radiation. When comparing demographics prior to treatment between the two groups, there were no significant differences in age, gender, type of primary malignancy, cumulative radiation dosage, latency period, duration from treatment to end of radiotherapy, duration of bleeding, albumin level, body mass index (BMI), concomitant radiation uropathy, radiation enteritis, and associated risk factors of CRP such as previous history of abdominal surgery, diabetes mellitus and hypertension (Table 2). Thus, these above characteristics were comparable between the two groups. However, the colostomy group had a higher score of bleeding (2.7 vs 2.0, P < 0.001) and a lower hemoglobin level (60.8 g/L vs 88.2 g/L, P < 0.001), when compared to the conservative treatment group, respectively. These results indicated that the colostomy group had more serious bleeding before treatment (Table 2).

Table 2 Comparisons of patient demographics between the colostomy group and conservative group before treatment n (%).

Characteristics	Diverting colostomy (n = 22)	Conservative treatment (n = 25)	P value
Age (mean ± SD)	60.1 ± 2.2	60.2 ± 2.4	0.964
Gender (female/male)	20/2	23/2	1.0001
Primary malignancy			0.8222
Cervical cancer	19 (86.4)	21 (84)
Endometrial cancer	2 (9.1)	2 (8)
Rectal cancer	1 (4.5)	1 (4)
Prostate cancer	0 (0)	1 (4)
Cumulative radiation dosage (Gy), mean ± SD	80.5 ± 17.3	83.6 ± 20.5	0.8423
Latency period (mo), mean ± SD	8.3 ± 0.8	7.2 ± 1.1	0.2523
Duration from treatment to end of radiotherapy (mo), mean ± SD	16.3 ± 1.3	14.8 ± 1.6	0.2773
Duration of bleeding (month), mean ± SD	7.9 ± 1.0	8.0 ± 1.8	0.4661
Score of bleeding, mean ± SD	2.7 ± 0.5	2.0 ± 0.5	< 0.0013
Mean hemoglobin (g/L), mean ± SD	60.8 ± 18.1	88.2 ± 19.3	< 0.001
Alb (g/L), ( ≤ 35/> 35)	6/16	3/22	0.3391
BMI (kg/m2), ( ≤ 17.5/> 17.5)	3/19	2/23	0.8801
Concomitant radiation uropathy	8 (36.4)	6 (24)	0.355
Radiation enteritis	5 (22.7)	2 (8)	0.3151
Previous abdominal surgery	6 (27.3)	11 (44)	0.234
Diabetes mellitus	2 (9.1)	3 (12)	1.0001
Hypertension	6 (27.3)	7 (28)	0.956

¹χ² test;

²Fisher exact test;

³Wilcoxon rank-sum test. BMI: Body mass index; Alb: Albumin.

Figure 2 Flow chart of patient selection.

Treatment

The indications for colostomy were as follows: (1) severe bleeding in eight (36.4%) cases; (2) fistulas in 11 (50%), including nine (40.9%) rectovaginal fistulas and two (9.1%) sigmoid-vesical-vaginal fistulas; (3) deep ulcer + refractory perianal pain in two (9.1%) cases; and (4) severe bleeding + deep ulcer + anal stricture in one (4.5%) case. Among these 11 patients with fistulas, five also had concomitant severe bleeding. Among these nine recto-vaginal fistulas, one had concomitant recto-urethral fistula, and another had concomitant recto-vesical fistula and small bowel fistula.

In the conservative treatment group, seven patients received topical formalin irrigation and one received APC treatment after enrollment. All eight (32%) cases transiently obtained bleeding remission, but only two (25%) obtained long-term remission of bleeding. The other six patients experienced recurrent bleeding and developed severe anemia. Repeat topical formalin achieved only limited efficacy in these patients with severe anemia (average 2 sessions of formalin at 2-4-wk intervals). The remaining 17 patients refused formalin treatment, and thus continued retention enemas and transfusions when needed.

Outcomes

During a mean 22 (range: 6-77) mo of follow-up, eight (17%) patients died. The cause of death was recurrent malignancy in seven cases. The other one died of bladder perforation and sepsis that occurred secondary to radiation recto-vesical-vaginal perforation. At 6 mo after treatment, colostomy offered higher remission of bleeding (94% vs 12%, P < 0.001), higher remission of refractory perianal pain (100% vs 0%, P < 0.001), decreased scores of bleeding (1.1 vs 2.2, P < 0.001), and obvious increased hemoglobin levels (34.1 g/dL vs -12.3 g/dL, P < 0.001), compared to the conservative treatment group. At 1 year after treatment, colostomy achieved still higher remission of both moderate bleeding (100% vs 21.5%, P = 0.002) and severe bleeding (100% vs 0%, P < 0.001), acquired lower score of bleeding (0.8 vs 2.0, P < 0.001), and obviously elevated hemoglobin levels (40.3 g/dL vs -1.9 g/dL, P = 0.003), than those cases in the conservative treatment group. In addition, three recto-vaginal fistulas were found in the conservative treatment group during follow-up, but no new fistula occurred after the operation in the colostomy group. Patients who did not have bleeding remission continued conservative treatment at home (Table 3).

Table 3 Bleeding remissions in severe radiation proctitis after treatment.

Variables	Diverting Colostomy (n = 22)	Conservative treatment (n = 25)	P value
6 mo after treatment
Remission of bleeding	17/18 (94%)	3/25 (12%)	< 0.0011
Remission of refractory perianal pain	8/8 (100%)	0/6 (0%)	< 0.0012
Score of bleeding, mean ± SD	1.1 ± 0.5	2.2 ± 0.7	< 0.0013
Elevated Hb, mean ± SD	34.1 ± 18.2	-12.3 ± 9.14	< 0.001
Remission of moderate bleeding	8/8 (100%)	6/19 (21.5%)	0.0022
Remission of severe bleeding	11/11 (100%)	0/5 (0)	< 0.0012
Score of bleeding, mean ± SD	0.8 ± 0.5	2.0 ± 0.9	< 0.0013
Post-treatment recto-vaginal fistula	0/22	3/25 (12%)	0.2372
Elevated Hb, mean ± SD	40.3 ± 19.3	-1.9 ± 32.54	0.003

¹χ² test;

²Fisher exact test;

³Wilcoxon rank-sum test;

⁴Represents decreased level.

Stoma closure and complications

Of the eight patients who received colostomy to control severe bleeding, three (37.5%) underwent stoma closure (2 cases at 9 mo and 1 at 10 mo after colostomy). All three had no bleeding and remained well after stoma reversal. Of the remaining five, all obtained bleeding remission and improved hemoglobin levels. However, among these five, one had grade IV New York Heart Association heart failure and could not risk stoma closure. Four were unsuitable for closure because of erythema and telangiectasia at 6 mo after colostomy, and two of these four had not yet reached 1 year follow-up to assess the lesion by colonoscopy.

Stoma complications were found in seven (31.8%) cases, which contained six stoma prolapses and one stoma stricture. Of these six stoma prolapses, four were managed with conservative measures by manual repositions (Grade II by Clavien-Dindo classification[28]), and two required stoma rebuilding (Grade III). One stoma stricture occurred in a stoma of the descending colon, instead of the transverse colon, and stoma stricture was managed by finger dilatation (Grade II).

Quality of life

The quality of life was evaluated in 41 (87.2%) patients by the EORTC QLQ-C30 questionnaires. Because there were no similar reports in the Chinese population, the values were referred to the normal German population. Osoba et al[29] suggested that a difference of ≥ 20 points in global health was considered to be clinically relevant. In this study, when compared to pre-treatment, diverting colostomy improved quality of life, including improved global health (difference = 42, P < 0.001), improved functions like physical function (P < 0.001), role function (P < 0.001), emotional function (P < 0.001), social function (P < 0.001), and improved symptoms like fatigue (P < 0.001), pain (P = 0.001), dyspnea (P = 0.003), insomnia (P = 0.026), and diarrhea (P = 0.018). However, conservative treatment did not significantly improve quality of life at follow-up compared with before treatment (Table 4).

Table 4 Quality of life between diversion group and conservative group in CRP patients by EORTC QLQ-C30 scale.

QLQ-C30 scale	Ref. (Normal German population)	Diverting colostomy group (n = 18), mean (SD)				Conservative treatment group (n = 23), mean (SD)
		Pre-treatment	Follow-up	Δ(FU)-Pre1	Significance2	Pre-treatment	Follow-up	Δ(FU)-Pre	Significance2
Global health	63.2	23.1 (15.1)	64.8 (13.8)	41.7	< 0.001	47.1 (21.5)	62.3 (25.0)	15.2	0.033
Physical function	82.6	50.7 (17.8)	77.8 (16.6)	27.1	< 0.001	78.0 (22.7)	78.6 (26.1)	0.6	0.856
Role function	75.0	34.3 (23.9)	75.9 (27.3)	41.6	< 0.001	77.5 (24.9)	77.5 (29.1)	0.0	0.775
Emotional function	62.2	46.3 (27.4)	73.6 (27.0)	27.3	0.001	75.7 (17.6)	80.8 (23.8)	5.1	0.384
Cognition function	81.3	92.6 (12.7)	93.5 (9.8)	0.9	0.581	94.2 (15.6)	95.7 (9.0)	1.5	0.798
Social function	78.4	43.5 (28.9)	65.7 (31.7)	22.2	0.004	91.3 (20.6)	89.1 (21.1)	-2.2	0.916
Fatigue	34.1	72.8 (12.9)	36.4 (25.9)	-36.4	< 0.001	26.6 (24.1)	23.2 (27.2)	-3.4	0.695
Nausea/vomiting	5.7	4.6 (15.5)	1.9 (7.6)	-2.7	0.109	5.1 (15.4)	6.5 (16.5)	1.4	0.655
Pain	33.1	44.4 (28.3)	14.8 (22.8)	-29.6	0.001	14.5 (21.5)	11.6 (18.4)	-2.9	0.481
Dyspnea	18.8	42.6 (31.0)	18.5 (22.8)	-24.1	0.003	14.5 (19.7)	8.7 (18.0)	-5.8	0.210
Insomnia	38.5	48.1 (35.5)	29.6 (31.2)	-18.5	0.026	21.7 (21.6)	26.1 (31.7)	4.4	0.287
Appetite loss	9.4	22.2 (27.2)	13.0 (19.7)	-9.2	0.125	10.1 (25.5)	8.7 (18.0)	-1.4	0.785
Constipation	9.1	9.3 (14.9)	3.7 (10.5)	-5.6	0.066	8.7 (20.6)	7.2 (22.4)	-1.5	0.414
Diarrhea	9.2	33.3 (33.3)	22.2 (24.8)	-11.1	0.018	11.6 (23.8)	2.9 (9.6)	-8.7	0.078
Financial difficulties	17.1	59.3 (26.2)	50.0 (31.9)	-9.3	0.211	26.1 (31.7)	24.6 (30.5)	-1.5	0.595

¹Wilcoxon rank-sum test;

²Point (follow-up) - point (pre-treatment).

Endoscopic and pathological features

Classical endoscopic images prior to colostomy and at stoma closure from three patients with stoma closures were collected (Figure 3). After a mean 9.3 (range: 9-10) mo after colostomy, endoscopic lesions of active bleeding, multiple confluent telangiectasia, congested mucosa, or even ulcer were greatly improved and reached the criteria of stoma closure.

Figure 3 Classical endoscopic images before colostomy and at stoma reversal. Severe active bleeding (A and C), or confluent telangiectasia, edema and ulcer (E) were observed in cases 1-3 before colostomy, while these lesions was greatly improved at stoma reversal (B, D, F).

Pathological evaluation of endoscopic biopsy from rectal lesions was conducted at 31 mo after colostomy in Case 3. This patient obtained complete remission of bleeding and the biopsy sites were fully healed according to endoscopic observation at follow-up. Pathologically, diffuse chronic inflammatory cells were observed in the mucosa and sub-mucosa layers. In addition, massive fibrotic collagen depositions were found in the sub-mucosa layer, which revealed fibrosis formation (Figure 4).

Figure 4 Histo-pathological features after colostomy in case 3. Complete remission of confluent telangiectasia, edema and ulcer were observed 31 mo after colostomy (A and B). Diffused chronic inflammatory cells and rebuilt of mucosal integrity were seen in hematoxylin and eosin-stained slides (C: × 100; D: × 400). Massive fibrotic collagen depositions were observed in the sub-mucosa layer, with green color by Masson staining (E: × 100; F: × 400).

DISCUSSION

Endoscopic treatments, such as topical formalin or APC, are extensively used for mild to moderate hemorrhagic CRP worldwide[14,16]. However, these treatments show only limited long-term efficacy for severe CRP[17]. It is also unclear how many patients have received these treatments for serious transfusion-dependent bleeding in previous studies[17]. Meanwhile, serious complications can be caused by these endoscopic treatments[5,17]. Our previous study also suggested that topical formalin should not be applied in CRP with ulcer because of the risk of fistula[24]. In the present study, patients in the conservative treatment group received more topical formalin or APC treatment and developed more fistulas later, than patients in the colostomy group. Therefore, we suggest topical formalin or APC should be selected cautiously for patients with severe CRP. Recently, radiofrequency ablation (RFA) in treating CRP has been introduced, with improvement in hemoglobin level and decrease in clinical symptoms[30,31]. Most RFA studies are based on retrospective case series without controls and current data are scare, therefore, prospective trials of RFA should be conducted in the future to validate its efficacy and application in severe CRP.

Surgical intervention is often the last resort for severe CRP[3,19]. Rectal resection is controversial, because it is difficult to perform a safe anastomosis in the radiation-injured tissue, and high risks of anastomotic leak and death from postoperative peritonitis are reported[19]. Therefore, a simple and safe procedure to save life and relive symptoms is mandatory. Theoretically, diverting colostomy can reduce bacterial contamination and decrease irritation injury by fecal stream, and colostomy can gain time to subside any radiation reaction to protect injured tissue[32]. Thus, severe bleeding and refractory perianal pain can be controlled. Colostomy can also accelerate the course of fibrosis and relieve severe proctitis rapidly, which may prevent deep ulcers progressing to fistulas. In our recent study[33], we reported typical histopathological features of CRP: telangiectasia, abnormal hyaline-like wall vessels and sporadic radiation fibrocytes in the submucosal layer. In this study, consistently, massive fibrotic collagen depositions were observed in irradiated tissue after colostomy. Collectively, the nature of CRP is a progressive fibrosis course[7]. The efficacy and safety of colostomy have been reported in previous studies[18,19,34]. However, most previous studies did not contain controls, which could not discriminate the efficacy of interventions from the self-remission course. To the best of our knowledge, no previous study has reported quality of life after colostomy. It is also not clear whether colostomy can reduce serious CRP complications.

In this study, diverting colostomy resolved most cases of severe bleeding. No recurrent bleeding and no colostomy-related death were observed. Colostomy can also decrease serious complications, including remission of long-term perianal pain, transfusion-dependent bleeding and fistula. Deep ulcer with severe bleeding is a contraindication to endoscopic treatment, because it is easy to progress to fistula, due to the poor-healing capacity and impaired blood supply of friable intestinal wall[17,19]. We have previously tried topical revision and skin flap transplantation for some CRP fistulas. However, the efficacy was limited and new fistulas can occur rapidly, due to poor healing capacity of irradiated mucosa and bacterial infection from the fecal stream, which leads to treatment failure. In this study, two patients with deep ulcer and severe bleeding were successfully controlled by colostomy, and no fistula was found at follow-up.

Transverse colostomy is preferred because it provides a greater blood supply by preserving superior rectal and left marginal vessels, and provides more options for later possible recto-sigmoid resection than sigmoid colostomy does, and transverse colostomy is easier to be closed and is more effective[32,34]. In addition, the recto-sigmoid colon is expected to receive a higher radiation dose for pelvic malignancy, while the transverse colon receives the least radiation and damage, because it is located far from pelvic tumors, and thus causes the fewest complications[19,32,35]. Loop ileostomy is not widely used because of the risk of high-volume fluid discharge. Colostomy-related complications were reported, ranging from 21.8% to 40%[19,35]. Consistent with previous studies, colostomy-related complications in this study were 31.8%, including six (85%) cases of Grade II and one (15%) case of Grade III complications. Among them, stoma prolapse was a common complication.

Colostomy for recto-vaginal fistula and rectal stricture is permanent. However, colostomy for patients unresponsive to medical treatment can be closed when severe proctitis improves sufficiently. Anseline et al[19] reported six (43%) colostomy reversals in 14 CRP patients, who were unresponsive to medical treatment. A similar result was observed in the present study. Three (38%) of eight patients with severe bleeding were closed successfully in a mean 9 mo after colostomy. Because the duration of follow-up after fecal diversion was short, many patients who obtained long-term remission of bleeding after colostomy had great potential to reverse the stoma.

In this study, we used a modified SOMA system, which coordinates subjective bleeding symptoms and objective accurate hemoglobin level. According to the system, we suggest that mild to moderate hemorrhagic CRP can be managed by medical or endoscopic treatment. However, for severe refractory bleeding colostomy should be considered to prevent development of serious complications. The scoring system will guide physicians in primary care to evaluate patient condition according to hemoglobin level, and then choose the appropriate treatment. Having a routine and easy protocol can reduce treatment-related delays and avoid unnecessary morbidity[7].

In this study, 44 (94%) CRP patients enrolled had gynecological cancers, so most fistulas were documented in women. In western countries, patients with prostate cancer are the dominant population receiving pelvic radiation, and CRP is mainly reported in prostate cancer[4,12]. However, prostate cancer receives only external beam radiation such as 3D conformal radiotherapy or intensity-modulated radiotherapy, and it does not receive intra-cavity brachytherapy, thus, fewer fistulas are observed. According to our clinical practice, intra-cavity radiation can result in more fistulas and other severe adverse radiation-related symptoms than external beam radiation can.

Although the colostomy group had more severe bleeding than the conservative treatment group, which could have resulted in selection bias, it achieved dramatically better control of bleeding, higher increased hemoglobin level, and improved quality of life compared with the conservative treatment group. These results have shown the advantages of diverting colostomy in treating severe CRP bleeding. Topical formalin or APC was not used in all the patients in the conservative treatment group, because some patients in China have not sufficient knowledge of CRP, poor compliance with physicians’ advice, and poor economic status. Thus, they choose to continue self-enemas at home, when recurrent bleeding occurs. In addition, this study was limited by its non-randomized, retrospective design and small sample size. Additional randomized prospective studies of diverting colostomy are needed to confirm our findings.

ACKNOWLEDGMENTS

The authors thank Jie Zhao, Li-Li Chu for the contributions in the collection of stoma pictures and providing stoma cares. We also thank Yan-Qi Liu for the contribution in patient follow-up.

COMMENTS

Background

Chronic radiation proctitis (CRP) occurs in 5%-20% of patients receiving radiotherapy for pelvic malignant tumors. Mild to moderate CRP is usually self-limiting and easy to manage, but severe and refractory bleeding is still problematic, especially in cases requiring blood transfusions and that are life threatening. Furthermore, endoscopic treatment can cause severe side effects and only limited efficacy can be obtained for severe CRP. Thus, a simple and safe treatment with fewer complications to save life and relive symptoms is mandatory.

Research frontiers

Diverting colostomy has been reported previously, mainly for severe CRP complications. However, unlike formalin or argon plasma coagulation, colostomy is now not widely used for severe bleeding in CRP patients. The issue of colostomy is not well studied to date. To the best of our knowledge, no study has compared diverting colostomy to conservative measures in treating severe hemorrhagic CRP.

Innovations and breakthroughs

In this series, the authors reported their experience that diverting colostomy was a simple, effective and safe procedure for severe hemorrhagic CRP. Furthermore, they found that colostomy improved quality of life and reduced serious complications secondary to radiotherapy, while conservative medical and endoscopic treatments did not show efficacy in severe CRP patients.

Applications

Diverting colostomy is a simple and safe procedure that can be performed in most medical centers. The authors also developed a modified Subjective Objective Management Analysis system, which coordinates subjective bleeding symptoms and objective accurate hemoglobin level, to guide physicians in primary care to evaluate patient condition according to hemoglobin level, and then choose the appropriate treatment. Having a routine and easy protocol can reduce treatment-related delays and avoid unnecessary morbidity.

Terminology

The underlying causes of CRP are endarteritis obliterans and progressive submucosal fibrosis due to radiotherapy. Diverting colostomy can reduce bacterial contamination and decrease irritation injury by the fecal stream, and can gain time to reduce any radiation reaction to protect injured tissue. Colostomy can also accelerate the course of fibrosis and relieve severe proctitis rapidly, which may prevent deep ulcers progressing to fistulas.

Peer-review

This is a single center, controlled, and retrospective case series of severe CRP patients who received diverting colostomy. Colostomy can relieve most of severe bleeding rapidly and unexpected, colostomy can also reduce serious CRP complications, including remission of long-term perianal pain, transfusion-dependent bleeding and fistula.